What is the address of SOINS INFIRMIERS COPPEE JULIE?

The registered office of SOINS INFIRMIERS COPPEE JULIE is located at Rue des Sables 5, 7020 Mons.

Is SOINS INFIRMIERS COPPEE JULIE still active?

Yes. According to the CBE (17 September 2026) SOINS INFIRMIERS COPPEE JULIE is active, legal situation “Normale toestand”, started on 16 November 2016.

Is SOINS INFIRMIERS COPPEE JULIE registered on Peppol?

Yes, SOINS INFIRMIERS COPPEE JULIE is registered on the Peppol network with ID 0208:0666412764.

What is the enterprise number of SOINS INFIRMIERS COPPEE JULIE?

The enterprise number of SOINS INFIRMIERS COPPEE JULIE is BE0666412764.

When was SOINS INFIRMIERS COPPEE JULIE founded?

SOINS INFIRMIERS COPPEE JULIE was founded on 16 November 2016.

Is SOINS INFIRMIERS COPPEE JULIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 November 2016; 5 annual accounts filed, latest fiscal year 2025.

How much profit did SOINS INFIRMIERS COPPEE JULIE make in 2025?

SOINS INFIRMIERS COPPEE JULIE posted a profit after taxes of € 68,945 in financial year 2025.

What is the revenue of SOINS INFIRMIERS COPPEE JULIE?

As a small company, SOINS INFIRMIERS COPPEE JULIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 108,705.

SOINS INFIRMIERS COPPEE JULIE (Private Limited) - Mons

Dossier SOINS INFIRMIERS COPPEE JULIE, printed on 17 September 2026 from databakkes.be/en/0666412764/soins-infirmiers-coppee-julie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

SOINS INFIRMIERS COPPEE JULIE from Mons, company number BE0666412764, closed financial year 2025 with a result of € 68,945 after tax. For that financial year SOINS INFIRMIERS COPPEE JULIE recorded a gross margin of € 108,705 and equity of € 20,454. Compared with financial year 2024, the result moved from € 51,377 to € 68,945. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 10, 2026.

What it is worth Healthy

€ 20,454

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 68,945

▲ 34% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 71

▲ 73% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 68,945 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Wage cost

€ 1,174

▼ 9% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 102,304

▲ € 96,418 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 100,000

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 117

▼ 99% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 49,557

▲ 91% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 32,620 Gross margin 2022: € 32,620 First fiscal year in the series	€ 19,573 Gross margin 2023: € 19,573 ▼ 40% vs 2022 (€ 32,620) Unfavourable step	€ 83,281 Gross margin 2024: € 83,281 ▲ € 63,708 vs 2023 (€ 19,573) Favourable step	€ 108,705 Gross margin 2025: € 108,705 ▲ 31% vs 2024 (€ 83,281) Favourable step	▲ 31%
Profit after taxes	€ 5,122 Profit after taxes 2022: € 5,122 First fiscal year in the series	€ 0 Profit after taxes 2023: € 0 ▼ 100% vs 2022 (€ 5,122) Unfavourable step	€ 51,377 Profit after taxes 2024: € 51,377 Unchanged (€ 0) Favourable step	€ 68,945 Profit after taxes 2025: € 68,945 ▲ 34% vs 2024 (€ 51,377) Favourable step	▲ 34%
Equity	€ 25,575 Equity 2022: € 25,575 First fiscal year in the series	€ 25,575 Equity 2023: € 25,575 Unchanged (€ 25,575) Unchanged	€ 20,454 Equity 2024: € 20,454 ▼ 20% vs 2023 (€ 25,575) Unfavourable step	€ 20,454 Equity 2025: € 20,454 Unchanged (€ 20,454) Unchanged
Total debts	€ 78,168 Total debts 2022: € 78,168 First fiscal year in the series	€ 42,001 Total debts 2023: € 42,001 ▼ 46% vs 2022 (€ 78,168) Favourable step	€ 37,974 Total debts 2024: € 37,974 ▼ 10% vs 2023 (€ 42,001) Favourable step	€ 207,569 Total debts 2025: € 207,569 ▲ € 169,595 vs 2024 (€ 37,974) Unfavourable step	▲ € 169,595
Cash	-	€ 4,071 Cash 2023: € 4,071 First fiscal year in the series	€ 41 Cash 2024: € 41 ▼ 99% vs 2023 (€ 4,071) Unfavourable step	€ 71 Cash 2025: € 71 ▲ 73% vs 2024 (€ 41) Favourable step	▲ 73%
Retained profit	€ 6,975 Retained profit 2022: € 6,975 First fiscal year in the series	€ 6,975 Retained profit 2023: € 6,975 Unchanged (€ 6,975) Unchanged	€ 1,854 Retained profit 2024: € 1,854 ▼ 73% vs 2023 (€ 6,975) Unfavourable step	€ 1,854 Retained profit 2025: € 1,854 Unchanged (€ 1,854) Unchanged
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 56,499 Dividend 2024: € 56,499 Unchanged (€ 0) Unchanged	€ 68,945 Dividend 2025: € 68,945 ▲ 22% vs 2024 (€ 56,499) Unchanged	▲ 22%
Bank debt	€ 65,900 Bank debt 2022: € 65,900 First fiscal year in the series	€ 39,700 Bank debt 2023: € 39,700 ▼ 40% vs 2022 (€ 65,900) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 39,700) Favourable step	€ 100,000 Bank debt 2025: € 100,000 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 103,743 Balance sheet total 2022: € 103,743 First fiscal year in the series	€ 67,577 Balance sheet total 2023: € 67,577 ▼ 35% vs 2022 (€ 103,743) Unchanged	€ 58,428 Balance sheet total 2024: € 58,428 ▼ 14% vs 2023 (€ 67,577) Unchanged	€ 228,023 Balance sheet total 2025: € 228,023 ▲ 290% vs 2024 (€ 58,428) Unchanged	▲ 290%

Key figures of SOINS INFIRMIERS COPPEE JULIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to SOINS INFIRMIERS COPPEE JULIE?

What happened at SOINS INFIRMIERS COPPEE JULIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 10, 2026 New annual accounts for financial year 2025: profit of € 68,945 (▲ 34% vs 2024). filed late Source: NBB ↗
Nov 21, 2016 New establishment in Mons. KBO
Nov 16, 2016 Start of the company according to the CBE. KBO

In short

From € 5,122 profit in 2022 to € 68,945 profit in 2025.

Paid € 44,672 in corporate taxes since 2022.

Best year ever: 2025, with € 68,945 profit.

Paid out € 125,444 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at SOINS INFIRMIERS COPPEE JULIE? We notify you, reason included.

Follow SOINS INFIRMIERS COPPEE JULIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit